Skip to main content
. 2024 Nov 6;16(22):3752. doi: 10.3390/cancers16223752

Figure 5.

Figure 5

Drug combination evaluation. BC cells were treated with trastuzumab and NextA both alone and in combination. MTS CellTiter96® Aqueous One Solution cell proliferation assay was used to determine cell viability. The BLISS synergy score was evaluated using the SynergyFinder.org web application. Score < −10 antagonism, between −10 and 10 additivity, >10 synergism.